I betragtning af behandlingens fordele og den relativt lave forekomst af bivirkninger, således som den fremgår af undersøgelserne efter markedsføringen, anses benefit/ risk- forholdet for gunstigt.
Taking the benefit of the treatment into account and the relatively low level of adverse effects, as it appears from PMS studies, the risk/ benefit balance is considered favourable.